Celgene - 28 Year Stock Price History | CELG

Historical daily share price chart and data for Celgene since 1990 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Celgene as of November 16, 2018 is 69.65.
Celgene Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 87.4185 106.1600 109.1400 69.6300 69.6500 -33.26%
2017 122.8241 118.7500 146.5200 98.1700 104.3600 -9.84%
2016 106.5224 117.6200 124.1600 94.8500 115.7500 -3.35%
2015 118.4049 113.5200 139.0100 104.7900 119.7600 7.06%
2014 87.8837 85.9700 118.6800 68.4500 111.8600 32.40%
2013 65.3128 40.5500 85.3850 40.5500 84.4840 115.33%
2012 36.5400 34.3300 41.0400 29.7225 39.2350 16.08%
2011 29.5968 30.0100 34.0050 24.7500 33.8000 14.31%
2010 28.7659 27.8700 32.5100 24.5100 29.5700 6.21%
2009 24.7388 28.2450 28.8950 19.0050 27.8400 0.72%
2008 30.5196 23.1500 38.5050 23.1500 27.6400 19.63%
2007 29.9269 28.6000 37.5900 23.1050 23.1050 -19.68%
2006 21.9143 16.2200 29.8100 16.2200 28.7650 77.56%
2005 10.9370 6.5750 16.2125 6.2925 16.2000 144.34%
2004 6.5894 5.6513 8.0225 4.9013 6.6300 18.18%
2003 4.2095 2.7350 5.9550 2.6238 5.6100 109.03%
2002 2.6090 3.9250 3.9250 1.4375 2.6838 -32.74%
2001 3.3703 4.0475 4.7875 1.9013 3.9900 -1.78%
2000 6.0963 2.8204 9.3438 2.3646 4.0625 39.28%
1999 1.0105 0.6875 2.9688 0.4792 2.9167 355.17%
1998 0.4036 0.3594 0.6929 0.2188 0.6408 82.25%
1997 0.3735 0.4792 0.5417 0.2240 0.3516 -24.11%
1996 0.5131 0.5442 0.7760 0.2813 0.4633 -16.90%
1995 0.3257 0.2240 0.5575 0.1901 0.5575 137.84%
1994 0.2937 0.2917 0.3698 0.2344 0.2344 -19.64%
1993 0.4205 0.5208 0.5783 0.2865 0.2917 -46.68%
1992 0.5106 0.6458 0.8125 0.3073 0.5471 -13.90%
1991 0.4590 0.2604 0.8646 0.2604 0.6354 134.64%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $48.703B $13.003B
Celgene Corporation is a global biopharmaceutical company engaged in the discovery, development and commercialization of innovative therapies for the treatment of cancer and immune-inflammatory related diseases. Their portfolio of commercial products include REVLIMID, VIDAZA, THALOMID, POMALYST/IMNOVID, ABRAXANE, OTEZLA, ISTODAX and IDHIFA. The drug candidates in their pipeline are at various stages of preclinical and clinical development. These candidates include their IMiDs compounds, which are a proprietary class of compounds that have certain immunomodulatory and other biologically important properties in addition to their leading oral anti-inflammatory agents and cellular therapies. They believe their commercial stage products and the depth of their product pipeline, provide the catalysts for future growth.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $123.735B 13.99
Gilead Sciences (GILD) United States $89.519B 10.78
Biogen (BIIB) United States $65.291B 13.22
Illumina (ILMN) United States $47.030B 54.78
Vertex Pharmaceuticals (VRTX) United States $42.195B 73.71
Regeneron Pharmaceuticals (REGN) United States $37.368B 18.93
Alexion Pharmaceuticals (ALXN) United States $26.464B 18.11
BioMarin Pharmaceutical (BMRN) United States $17.041B 0.00
Incyte (INCY) United States $14.154B 391.24
Seattle Genetics (SGEN) United States $9.197B 0.00
Exact Sciences (EXAS) United States $8.773B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.028B 51.33
Sarepta Therapeutics (SRPT) United States $7.955B 0.00
QIAGEN (QGEN) Netherlands $7.897B 25.26
Alnylam Pharmaceuticals (ALNY) United States $7.391B 0.00
Bluebird Bio (BLUE) United States $6.855B 0.00
BeiGene (BGNE) Cayman Islands $6.829B 0.00
Bio-Techne Corp (TECH) United States $6.051B 40.88
Galapagos (GLPG) Belgium $5.361B 0.00
Alkermes (ALKS) Ireland $5.359B 3449.00
Exelixis (EXEL) United States $5.358B 15.19
Amarin (AMRN) Ireland $5.306B 0.00
Immunomedics (IMMU) United States $3.692B 0.00
Horizon Pharma Public (HZNP) Ireland $3.664B 15.08
Emergent Biosolutions (EBS) United States $3.631B 30.59
MorphoSys AG Unsponsored ADR (MOR) Germany $3.603B 0.00
Array BioPharma (ARRY) United States $3.490B 0.00
Ligand Pharmaceuticals (LGND) United States $3.283B 25.12
Allogene Therapeutics (ALLO) United States $3.224B 0.00
Guardant Health (GH) United States $3.113B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.045B 0.00
ARGENX SE-ADR (ARGX) Netherlands $2.999B 0.00
Repligen (RGEN) United States $2.871B 89.66
Genomic Health (GHDX) United States $2.753B 92.93
Ultragenyx Pharmaceutical (RARE) United States $2.694B 0.00
Akcea Therapeutics (AKCA) United States $2.675B 0.00
Ascendis Pharma (ASND) Denmark $2.497B 0.00
Allakos (ALLK) United States $2.484B 0.00
China Biologic Products (CBPO) China $2.467B 17.56
Blueprint Medicines (BPMC) United States $2.425B 0.00
Acceleron Pharma (XLRN) United States $2.413B 0.00
MyoKardia (MYOK) United States $2.384B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.368B 0.00
Myriad Genetics (MYGN) United States $2.348B 23.27
Halozyme Therapeutics (HALO) United States $2.332B 52.03
REGENXBIO (RGNX) United States $2.319B 31.11
Arena Pharmaceuticals (ARNA) United States $2.059B 0.00
Amicus Therapeutics (FOLD) United States $2.035B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $1.928B 0.00
Global Blood Therapeutics (GBT) United States $1.897B 0.00
AnaptysBio (ANAB) United States $1.835B 0.00
Denali Therapeutics (DNLI) United States $1.826B 0.00
Reata Pharmaceuticals (RETA) United States $1.779B 0.00
Aimmune Therapeutics (AIMT) United States $1.740B 0.00
Atara Biotherapeutics (ATRA) United States $1.702B 0.00
Innoviva (INVA) United States $1.651B 9.34
Rubius Therapeutics (RUBY) United States $1.599B 0.00
Cambrex (CBM) United States $1.587B 11.85
ORCHARD THERAPT (ORTX) United Kingdom $1.572B 0.00
G1 THERAPEUTICS (GTHX) United States $1.538B 0.00
NeoGenomics (NEO) United States $1.499B 123.92
Medicines (MDCO) United States $1.485B 0.00
Spark Therapeutics (ONCE) United States $1.479B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.408B 0.00
Editas Medicine (EDIT) United States $1.385B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.373B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.357B 0.00
Insmed (INSM) United States $1.331B 0.00
Mirati Therapeutics (MRTX) United States $1.331B 0.00
Myovant Sciences (MYOV) United Kingdom $1.329B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.253B 99.50
Solid Biosciences (SLDB) United States $1.199B 0.00
UniQure (QURE) Netherlands $1.187B 0.00
WAVE Life Sciences (WVE) Singapore $1.186B 0.00
Lion Biotechnologies (IOVA) United States $1.180B 0.00
Sangamo Therapeutics (SGMO) United States $1.144B 0.00
IMMURON LTD (IMRN) Australia $1.128B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.045B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.039B 0.00
Retrophin (RTRX) United States $1.038B 0.00
Audentes Therapeutics (BOLD) United States $1.005B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.988B 0.00
DBV Technologies (DBVT) France $0.951B 0.00
Acorda Therapeutics (ACOR) United States $0.941B 11.92
Lexicon Pharmaceuticals (LXRX) United States $0.924B 0.00
Cellectis (CLLS) France $0.915B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.907B 0.00
Puma Biotechnology (PBYI) United States $0.899B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.888B 0.00
Clovis Oncology (CLVS) United States $0.883B 0.00
Intra-Cellular Therapies (ITCI) United States $0.868B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.864B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.857B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.850B 0.00
Apellis Pharmaceuticals (APLS) United States $0.849B 0.00
Coherus BioSciences (CHRS) United States $0.835B 0.00
Viking Therapeutics (VKTX) United States $0.832B 0.00
Fate Therapeutics (FATE) United States $0.819B 0.00
Athenex (ATNX) United States $0.801B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.791B 0.00
Aptinyx (APTX) United States $0.783B 0.00
Revance Therapeutics (RVNC) United States $0.776B 0.00
Intellia Therapeutics (NTLA) United States $0.775B 0.00
Heska (HSKA) United States $0.770B 63.00
Dynavax Technologies (DVAX) United States $0.769B 0.00
Cara Therapeutics (CARA) United States $0.748B 0.00
TWIST BIOSCIENC (TWST) United States $0.748B 0.00
Vericel (VCEL) United States $0.736B 0.00
Novavax (NVAX) United States $0.697B 0.00
Gritstone Oncology (GRTS) United States $0.668B 0.00
InflaRx (IFRX) Germany $0.655B 0.00
CytomX Therapeutics (CTMX) United States $0.651B 0.00
UROGEN PHARMA (URGN) Israel $0.648B 0.00
AVROBIO (AVRO) United States $0.644B 0.00
AC Immune SA (ACIU) Switzerland $0.643B 0.00
ANI Pharmaceuticals (ANIP) United States $0.628B 12.00
Epizyme (EPZM) United States $0.627B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.621B 0.00
Senesco Technologies (ELOX) United States $0.611B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.608B 0.00
Principia Biopharma (PRNB) United States $0.606B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.568B 0.00
RA PHARMCTL INC (RARX) United States $0.541B 0.00
Arvinas (ARVN) United States $0.532B 0.00
UNITY Biotechnology (UBX) $0.520B 0.00
Eidos Therapeutics (EIDX) United States $0.519B 0.00
Arcus Biosciences (RCUS) United States $0.518B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.513B 0.00
Anika Therapeutics (ANIK) United States $0.507B 21.01
Scholar Rock Holding (SRRK) United States $0.506B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.498B 0.00
Kezar Life Sciences (KZR) United States $0.495B 0.00
Inovio Pharmaceuticals (INO) United States $0.488B 0.00
Mesoblast (MESO) Australia $0.480B 0.00
BeyondSpring (BYSI) United States $0.478B 0.00
Kura Oncology (KURA) United States $0.471B 0.00
ObsEva SA (OBSV) Switzerland $0.470B 0.00
Prothena (PRTA) Ireland $0.465B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.456B 0.00
Sorrento Therapeutics (SRNE) United States $0.454B 74.20
Replimune (REPL) United States $0.443B 0.00
PDL BioPharma (PDLI) United States $0.439B 7.17
Kindred Biosciences (KIN) United States $0.437B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.423B 0.00
Sinovac Biotech (SVA) China $0.421B 0.00
Five Prime Therapeutics (FPRX) United States $0.421B 0.00
MediciNova (MNOV) United States $0.413B 0.00
Zymeworks (ZYME) Canada $0.410B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.399B 0.00
Verastem (VSTM) United States $0.399B 0.00
Abeona Therapeutics (ABEO) United States $0.396B 0.00
Zealand Pharma (ZEAL) Denmark $0.376B 4.15
Cytokineticsorporated (CYTK) United States $0.369B 0.00
ResTORbio (TORC) United States $0.369B 0.00
Stemline Therapeutics (STML) United States $0.362B 0.00
Osiris Therapeutics (OSIR) United States $0.357B 0.00
MeiraGTx Holdings (MGTX) United States $0.351B 0.00
Kodiak Sciences (KOD) United States $0.350B 0.00
Liquidia Technologies (LQDA) United States $0.345B 0.00
Seres Therapeutics (MCRB) United States $0.335B 0.00
Cellular Biomedicine (CBMG) United States $0.319B 0.00
Merus (MRUS) Netherlands $0.318B 0.00
Albireo Pharma (ALBO) United States $0.316B 0.00
LogicBio Therapeutics (LOGC) United States $0.311B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.303B 0.00
Krystal Biotech (KRYS) United States $0.299B 0.00
Kadmon Holdings (KDMN) United States $0.296B 0.00
Geron (GERN) United States $0.296B 0.00
MannKind (MNKD) United States $0.287B 0.00
Sutro Biopharma (STRO) United States $0.285B 0.00
Athersys (ATHX) United States $0.285B 0.00
Equillium (EQ) United States $0.283B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.280B 0.00
Syros Pharmaceuticals (SYRS) United States $0.275B 0.00
BioDelivery Sciences (BDSI) United States $0.269B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.268B 0.00
Celyad SA (CYAD) Belgium $0.267B 0.00
Celcuity (CELC) United States $0.264B 0.00
Evelo Biosciences (EVLO) United States $0.263B 0.00
Arbutus Biopharma (ABUS) Canada $0.261B 0.00
Aduro Biotech (ADRO) United States $0.260B 0.00
Magenta Therapeutics (MGTA) United States $0.258B 0.00
Agenus (AGEN) United States $0.253B 0.00
TOCAGEN INC (TOCA) United States $0.247B 0.00
Axovant Sciences (AXON) United Kingdom $0.245B 0.00
Synlogic (SYBX) United States $0.243B 0.00
Unum Therapeutics (UMRX) United States $0.242B 0.00
Adverum Biotechnologies (ADVM) United States $0.240B 0.00
ADMA Biologics Inc (ADMA) United States $0.239B 0.00
Strongbridge Biopharma (SBBP) United States $0.238B 0.00
BioTime (BTX) United States $0.237B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.237B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.237B 0.00
GAMIDA CELL LTD (GMDA) Israel $0.233B 0.00
Urovant Sciences (UROV) United States $0.227B 0.00
Proteostasis Therapeutics (PTI) United States $0.225B 0.00
Kala Pharmaceuticals (KALA) United States $0.224B 0.00
Kamada (KMDA) Israel $0.214B 19.70
Xenon Pharmaceuticals (XENE) Canada $0.214B 0.00
Protagonist Therapeutics (PTGX) United States $0.212B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.210B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.204B 0.00
Idera Pharmaceuticals (IDRA) United States $0.203B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.199B 0.00
Intec Pharma (NTEC) Israel $0.195B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.193B 0.00
ChromaDex (CDXC) United States $0.192B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.188B 0.00
NantKwest (NK) United States $0.181B 0.00
Allena Pharmaceuticals (ALNA) United States $0.179B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.176B 0.00
Compugen (CGEN) Israel $0.170B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.165B 0.00
Menlo Therapeutics (MNLO) United States $0.162B 0.00
PSivida (EYPT) United States $0.162B 0.00
Palatin Technologies (PTN) United States $0.156B 19.27
Cerecor (CERC) United States $0.153B 0.00
Pfenex (PFNX) United States $0.149B 0.00
XBiotech (XBIT) United States $0.148B 0.00
Constellation Pharmaceuticals (CNST) United States $0.148B 0.00
Mersana Therapeutics (MRSN) United States $0.146B 0.00
Enzo Biochem (ENZ) United States $0.145B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.145B 0.00
Spero Therapeutics (SPRO) United States $0.141B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.137B 0.00
Cohbar (CWBR) United States $0.134B 0.00
Selecta Biosciences (SELB) United States $0.134B 0.00
Eleven Biotherapeutics (SESN) United States $0.132B 0.00
Catalyst Biosciences (CBIO) United States $0.131B 0.00
Pluristem Therapeutics (PSTI) Israel $0.127B 0.00
Applied Genetic Technologies (AGTC) United States $0.124B 0.00
Organovo Holdings (ONVO) United States $0.123B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.122B 0.00
XOMA (XOMA) United States $0.120B 0.00
Mustang Bio (MBIO) United States $0.116B 0.00
VBI Vaccines (VBIV) United States $0.115B 0.00
Motif Bio Plc (MTFB) United States $0.114B 0.00
OVID THERAPEUTC (OVID) United States $0.113B 0.00
Cue Biopharma (CUE) United States $0.112B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.111B 0.00
Anavex Life Sciences (AVXL) United States $0.110B 0.00
Cidara Therapeutics (CDTX) United States $0.108B 0.00
Signal Genetics (MGEN) United States $0.107B 0.00
CorMedix Inc (CRMD) United States $0.104B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.102B 0.00
Chiasma (CHMA) United States $0.094B 0.00
Provention Bio (PRVB) United States $0.094B 0.00
Neothetics (EVFM) United States $0.091B 0.00
BioXcel Therapeutics (BTAI) United States $0.090B 0.00
Orgenesis (ORGS) United States $0.088B 0.00
Aptose Biosciences (APTO) Canada $0.087B 0.00
Cel-Sci (CVM) United States $0.085B 0.00
Cocrystal Pharma (COCP) United States $0.085B 94.77
Axsome Therapeutics (AXSM) United States $0.084B 0.00
Checkpoint Therapeutics (CKPT) United States $0.081B 0.00
VolitionRX (VNRX) Singapore $0.081B 0.00
Ophthotech (OPHT) United States $0.080B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.079B 0.00
ScPharmaceuticals (SCPH) United States $0.076B 0.00
VTv Therapeutics (VTVT) United States $0.075B 0.00
PHASEBIO PHARMA (PHAS) United States $0.075B 0.00
ITUS (ANIX) United States $0.075B 0.00
Monster Digital (INNT) United States $0.074B 0.00
Alcobra (ARCT) United States $0.073B 0.00
Prima BioMed (IMMP) Australia $0.073B 0.00
Vaccinex (VCNX) United States $0.073B 0.00
Bionano Genomics (BNGO) United States $0.072B 0.00
Alimera Sciences (ALIM) United States $0.071B 0.00
Asterias Biotherapeutics (AST) United States $0.070B 0.00
NewLink Genetics (NLNK) United States $0.070B 0.00
Fortress Biotech (FBIO) United States $0.070B 0.00
Evogene (EVGN) Israel $0.069B 0.00
Versartis (ARAV) United States $0.067B 5.89
Protalix BioTherapeutics (PLX) Israel $0.066B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.065B 0.00
Aptevo Therapeutics (APVO) United States $0.065B 0.00
Entera Bio (ENTX) Israel $0.061B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.060B 0.00
Sophiris Bio (SPHS) United States $0.059B 0.00
Celldex Therapeutics (CLDX) United States $0.057B 0.00
Leap Therapeutics (LPTX) United States $0.056B 0.00
VistaGen Therapeutics (VTGN) United States $0.056B 0.00
Bellerophon Therapeutics (BLPH) United States $0.056B 0.00
Trevena (TRVN) United States $0.053B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.053B 8.50
Oncobiologics (ONS) United States $0.052B 0.00
Clearside Biomedical (CLSD) United States $0.052B 0.00
Curis (CRIS) United States $0.049B 0.00
OncoSec Medical (ONCS) United States $0.048B 0.00
AEterna Zentaris (AEZS) United States $0.048B 9.06
Caladrius Biosciences (CLBS) United States $0.047B 0.00
Zosano Pharma (ZSAN) United States $0.046B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.046B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.044B 0.00
Oncolytics Biotech (ONCY) Canada $0.044B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.041B 0.00
Vascular Biogenics (VBLT) Israel $0.039B 0.00
TRACON Pharmaceuticals (TCON) United States $0.039B 0.00
AZURRX BIOPHARM (AZRX) United States $0.038B 0.00
Moleculin Biotech (MBRX) United States $0.038B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.038B 0.00
GTx (GTXI) United States $0.036B 0.00
AquaBounty Technologies (AQB) United States $0.036B 0.00
Celsion (CLSN) United States $0.036B 0.00
VIVUS (VVUS) United States $0.034B 0.00
BioPharmX (BPMX) United States $0.033B 0.00
Galena Biopharma (SLS) United States $0.032B 0.00
Aileron Therapeutics (ALRN) United States $0.032B 0.00
Proteon Therapeutics (PRTO) United States $0.031B 0.00
Eyenovia (EYEN) United States $0.031B 0.00
Therapix Biosciences (TRPX) Israel $0.030B 11.23
Akari Therapeutics (AKTX) United Kingdom $0.027B 0.00
Vical (VICL) United States $0.027B 0.00
Advaxis (ADXS) United States $0.026B 0.00
Benitec Biopharma (BNTC) Australia $0.025B 0.00
OvaScience (OVAS) United States $0.024B 0.00
Cellect Biotechnology (APOP) Israel $0.023B 0.00
Edge Therapeutics (EDGE) United States $0.022B 0.00
GENPREX INC (GNPX) United States $0.021B 0.00
CytRx (CYTR) United States $0.020B 0.00
Cleveland BioLabs (CBLI) United States $0.020B 0.00
Pulmatrix (PULM) United States $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
Genetic Technologies (GENE) Australia $0.019B 0.00
Novelion Therapeutics (NVLN) Canada $0.019B 0.00
Arsanis (ASNS) United States $0.018B 0.00
Soligenix (SNGX) United States $0.018B 0.00
TrovaGene (TROV) United States $0.017B 0.00
Gemphire Therapeutics (GEMP) United States $0.017B 0.00
ATyr Pharma (LIFE) United States $0.017B 0.00
RestorGenex (DFFN) United States $0.016B 0.00
IBio (IBIO) United States $0.015B 0.00
Prana Biotechnology (PRAN) Australia $0.015B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.014B 0.00
Vital Therapies (VTL) United States $0.013B 0.00
Histogenics (HSGX) United States $0.013B 0.00
Novogen (KZIA) Australia $0.013B 0.00
Oragenics (OGEN) United States $0.011B 0.00
Synthetic Biologics (SYN) United States $0.011B 0.00
Cerulean Pharma (DARE) United States $0.011B 0.00
Hemispherx BioPharma (HEB) United States $0.010B 0.00
Adial Pharmaceuticals (ADIL) United States $0.009B 0.00
Neuralstem (CUR) United States $0.009B 0.00
Alliqua BioMedical (ALQA) United States $0.008B 0.00
Aytu Bioscience (AYTU) United States $0.008B 0.00
Titan Pharmaceuticals (TTNP) United States $0.008B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.008B 0.00
Flex Pharma (FLKS) United States $0.008B 0.00
AmpliPhi Biosciences (APHB) United States $0.008B 0.00
ARCA Biopharma (ABIO) United States $0.008B 0.00
MYOS RENS Technology (MYOS) United States $0.008B 0.00
Tenax Therapeutics (TENX) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.003B 0.00
OSMOTICA PHARM (OSMT) United States $0.000B 0.00